Sign in

CIK 0001583648 · Non-accelerated filer<br>Smaller reporting company

PALVELLA THERAPEUTICS, INC.

Sign in to watch
Ticker
PVLA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
300784346
Phone
(484) 253-1461
Business address
353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
Former names
PIERIS PHARMACEUTICALS, INC., Marika Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,725,861
in 7 filings, $11.7M under 10b5-1 plans

Net −$11,725,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-08-30 Olwill Shane Chief Development Officer Sale −9,200 $5.00 $46K 33,838
2021-08-30 Olwill Shane Chief Development Officer Sale −29,200 $5.15 $150K 4,638
2021-08-30 Olwill Shane Chief Development Officer Option exercise · Stock Option (right to buy) −38,400 61,600
2021-08-01 Demuth Tim Chief Medical Officer Grant or award · Stock Option (right to buy) +360,000 360,000
2021-06-25 Sherman Matthew L Director Grant or award · Stock Option (right to buy) +40,000 40,000
2021-06-25 Said Maya R. Director Grant or award · Stock Option (right to buy) +40,000 40,000
2021-06-25 Richman Michael Director Grant or award · Stock Option (right to buy) +40,000 40,000
2021-06-25 KIRITSY CHRISTOPHER P Director Grant or award · Stock Option (right to buy) +40,000 40,000
2021-06-25 Kiener Peter A Director Grant or award · Stock Option (right to buy) +40,000 40,000
2021-06-25 GERAGHTY JAMES A Director Grant or award · Stock Option (right to buy) +45,000 45,000
2021-06-25 Barbier Ann Director Grant or award · Stock Option (right to buy) +40,000 40,000
2021-03-04 Bures Thomas Vice President, Finance Grant or award · Stock Options (Right to buy) +150,000 150,000

Page 12 of 12 · 232 trades